CDK6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.332800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.452000E-01
Normal-vs-Stage2
8.238400E-01
Normal-vs-Stage3
4.616600E-01
Normal-vs-Stage4
4.608800E-01
Stage1-vs-Stage2
3.152400E-01
Stage1-vs-Stage3
7.959400E-01
Stage1-vs-Stage4
1.417150E-01
Stage2-vs-Stage3
2.961600E-01
Stage2-vs-Stage4
6.360400E-01
Stage3-vs-Stage4
1.374770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.751400E-01
Normal-vs-AfricanAmerican
5.922200E-01
Normal-vs-Asian
9.165000E-01
Caucasian-vs-AfricanAmerican
3.845000E-01
Caucasian-vs-Asian
8.778600E-01
AfricanAmerican-vs-Asian
5.516200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.511400E-01
Normal-vs-Female
9.025200E-01
Male-vs-Female
7.810400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.749400E-01
Normal-vs-Age(41-60Yrs)
6.185200E-01
Normal-vs-Age(61-80Yrs)
9.105000E-01
Normal-vs-Age(81-100Yrs)
8.448800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.151380E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.994400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.905180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.797700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.558800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.544800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.793400E-01
Normal-vs-Daily Drinker
3.801200E-01
Normal-vs-Weekly Drinker
8.153200E-01
Normal-vs-Occasional Drinker
8.430800E-01
Normal-vs-Social Drinker
5.653200E-01
Non Drinker-vs-Daily Drinker
2.929800E-01
Non Drinker-vs-Weekly Drinker
8.988400E-01
Non Drinker-vs-Occasional Drinker
4.639000E-01
Non Drinker-vs-Social Drinker
1.494430E-01
Daily Drinker-vs-Weekly Drinker
4.282800E-01
Daily Drinker-vs-Occasional Drinker
1.717160E-01
Daily Drinker-vs-Social Drinker
3.171900E-02
Weekly Drinker-vs-Occasional Drinker
4.919800E-01
Weekly Drinker-vs-Social Drinker
1.738410E-01
Occasional Drinker-vs-Social Drinker
6.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.067400E-01
Normal-vs-Grade 2
1.260830E-01
Normal-vs-Grade 3
1.141220E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.967920E-02
Grade 1-vs-Grade 3
4.524300E-03
Grade 1-vs-Grade 4
4.067400E-01
Grade 2-vs-Grade 3
1.681000E-01
Grade 2-vs-Grade 4
1.260830E-01
Grade 3-vs-Grade 4
1.141220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.877800E-01
Normal-vs-NonDiabetic
9.504000E-01
Diabetic-vs-NonDiabetic
5.310000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.246200E-01
Normal-vs-NoPancreatitis
9.776800E-01
Pancreatitis-vs-NoPancreatitis
4.276800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.019800E-01
Normal-vs-N1
7.950600E-01
N0-vs-N1
8.351600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.181600E-01
Normal-vs-TP53-NonMutant
8.570800E-01
TP53-Mutant-vs-TP53-NonMutant
5.379900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
